China National Medicines Corporation Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for China National Medicines Corporation Ltd. (600511.SS) is 2.18

According to China National Medicines Corporation Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.18. This represents a change of 2.50% compared to the average of 2.13 of the last 4 quarters.

China National Medicines Corporation Ltd. (600511.SS) Historical Current Ratio (quarterly & annually)

How has 600511.SS Current Ratio performed in the past?

The mean historical Current Ratio of China National Medicines Corporation Ltd. over the last ten years is 1.94. The current 2.18 Current Ratio has changed 11.14% with respect to the historical average. Over the past ten years (40 quarters), 600511.SS's Current Ratio was at its highest in in the March 2026 quarter at 2.18. The Current Ratio was at its lowest in in the December 2017 quarter at 1.75.

China National Medicines Corporation Ltd. (600511.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of China National Medicines Corporation Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China National Medicines Corporation Ltd. (600511.SS) Average Current Ratio

How has 600511.SS Current Ratio performed in the past?

The current Current Ratio of China National Medicines Corporation Ltd. (600511.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

China National Medicines Corporation Ltd. (600511.SS) Current Ratio vs. Peers

How is 600511.SS’s Current Ratio compared to its peers?

China National Medicines Corporation Ltd.’s Current Ratio is less than Hubei Jumpcan Pharmaceutical Co., Ltd. (5.46), less than Joincare Pharmaceutical Group Industry Co.,Ltd. (2.37), greater than Tasly Pharmaceutical Group Co., Ltd (0), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (2.67), less than Jilin Aodong Pharmaceutical Group Co., Ltd. (2.38), less than Jiangsu Nhwa Pharmaceutical Co., Ltd. (6.22), greater than ApicHope Pharmaceutical Co., Ltd (1.45), greater than Betta Pharmaceuticals Co., Ltd. (0.99), greater than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (2.16), less than Autobio Diagnostics Co., Ltd. (2.67),

Build a custom stock screener for China National Medicines Corporation Ltd. (600511.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China National Medicines Corporation Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China National Medicines Corporation Ltd. (600511.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China National Medicines Corporation Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.